Table 6.
Fold increase (post-/pre-vaccination)a of S.sonnei LPS-specific ALS and serum antibodies on day 7 among vaccine shedders and non-shedders in the 6-log dose group of adults.
| ALS |
Serum |
||||
|---|---|---|---|---|---|
| Participant# | WRSS1 Shedder/Non-shedder | LPS-IgA | LPS-IgG | LPS-IgA | LPS-IgG |
| 1 | Non-shedder | 63.7 | 19.4 | - | - |
| 2 | Shedder | 39.1 | 55.2 | 6.8 | - |
| 3 | Non-shedder | - | - | - | - |
| 4 | Non-shedder | 81.3 | 126.2 | 6.8 | - |
| 5 | Shedder | 15 | 64.3 | - | - |
| 6 | Shedder | 269.4 | 97.4 | 36.4 | 5.7 |
| 7 | Non-shedder | 310.7 | 1370.5 | 7.6 | 9.6 |
| 8 | Non-shedder | 244.6 | 179.5 | 1876 | - |
| 9 | Shedder | 109.9 | 170.9 | - | 6.9 |
| 10 | Shedder | 33.4 | 40.5 | 4.7 | - |
Data for each participant is given (intention to treat). a ≥ 4-fold increase was shown only; <4-fold increase in titers was indicated by ‘-’.